Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8943412rdf:typepubmed:Citationlld:pubmed
pubmed-article:8943412lifeskim:mentionsumls-concept:C0023281lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0009017lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0023276lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:8943412lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:8943412pubmed:issue11lld:pubmed
pubmed-article:8943412pubmed:dateCreated1996-12-27lld:pubmed
pubmed-article:8943412pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:abstractTextBALB/c mice are highly susceptible to infection with the protozoan parasite Leishmania major. This susceptibility has been attributed, in part, to the expansion of parasite-specific CD4+ Th2 cells that antagonize Th1 responses and promote humoral immunity. In the present study, we have utilized sera from L. major-infected BALB/c mice to screen an L. major amastigote cDNA expression library. One of the clones detected encodes a novel Ag designated as L. major stress-inducible 1 (LmSTI1). LmSTI1 contains six copies of the tetratricopeptide consensus motif and is highly related to a family of stress-inducible proteins that is conserved from yeast to humans. Sera from L. major-infected BALB/c mice have LmSTI1-specific Ab titers in excess of 1:200,000, comprised predominantly of IgG1, IgG2A, and IgG2B isotypes. Recombinant LmSTI1 protein elicited strong proliferative responses from draining lymph node cells of L. major-infected BALB/c mice at both early (10 days) and late (28 days) stages of infection and elicited production of high levels of IFN-gamma and low levels of IL-4. In contrast, soluble leishmanial lysate elicited high levels of IL-4 and low IFN-gamma production. Thus, we have identified an Ag of Leishmania capable of eliciting a mixed cellular response that is skewed toward a Th1 phenotype in susceptible BALB/c mice with advanced infections. In addition, analyses of sera from human patients with cutaneous, visceral, and post-kala azar visceral leishmaniasis indicated that a majority of individuals from all three clinical groups mounted strong humoral responses against LmSTI1.lld:pubmed
pubmed-article:8943412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:languageenglld:pubmed
pubmed-article:8943412pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8943412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8943412pubmed:statusMEDLINElld:pubmed
pubmed-article:8943412pubmed:monthDeclld:pubmed
pubmed-article:8943412pubmed:issn0022-1767lld:pubmed
pubmed-article:8943412pubmed:authorpubmed-author:Campos-NetoAAlld:pubmed
pubmed-article:8943412pubmed:authorpubmed-author:ReedS GSGlld:pubmed
pubmed-article:8943412pubmed:authorpubmed-author:WebbJ RJRlld:pubmed
pubmed-article:8943412pubmed:authorpubmed-author:KaufmannDDlld:pubmed
pubmed-article:8943412pubmed:issnTypePrintlld:pubmed
pubmed-article:8943412pubmed:day1lld:pubmed
pubmed-article:8943412pubmed:volume157lld:pubmed
pubmed-article:8943412pubmed:ownerNLMlld:pubmed
pubmed-article:8943412pubmed:authorsCompleteYlld:pubmed
pubmed-article:8943412pubmed:pagination5034-41lld:pubmed
pubmed-article:8943412pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:meshHeadingpubmed-meshheading:8943412-...lld:pubmed
pubmed-article:8943412pubmed:year1996lld:pubmed
pubmed-article:8943412pubmed:articleTitleMolecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.lld:pubmed
pubmed-article:8943412pubmed:affiliationInfectious Disease Research Institute, Seattle, WA 98104, USA.lld:pubmed
pubmed-article:8943412pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8943412pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8943412pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8943412lld:pubmed